Mean age (yr) | 62 ± 14 | 66 ± 17 | 0.41a |
< 50 yrs, n (%) | 1 (17) | 14 (14) | >0.99b |
≥ 50 yrs, n (%) | 5 (83) | 85 (86) | |
Sex, n (%) | | | 0.40b |
Male | 5 (83) | 57 (58) | |
Female | 1 (17) | 42 (42) | |
Indication for neuroimaging, n (%) | | | 0.08c |
Altered mental status | 1 (17) | 47 (47) | |
Trauma | 1 (17) | 24 (24) | |
Stroke symptoms | 4 (67) | 14 (14) | |
Headache | 0 (0) | 7 (7) | |
Seizure | 0 (0) | 3 (3) | |
Syncope | 0 (0) | 3 (3) | |
Dizziness | 0 (0) | 1 (1) | |
Comorbidities, n (%) | | | |
Current smoker | 0 (0) | 7 (7) | >0.99b |
Ex-smoker | 1 (17) | 8 (8) | 0.42b |
Hypertension | 3 (50) | 62 (63) | 0.67b |
Diabetes | 2 (33) | 38 (38) | >0.99b |
Obesity | 3 (50) | 20 (20) | 0.12b |
COPD/asthma/OSA | 2 (33) | 18 (18) | 0.32b |
Malignancy | 0 (0) | 11 (11) | >0.99b |
Cardiovascular disease | 1 (17) | 11 (11) | 0.53b |
Cerebrovascular disease | 0 (0) | 7 (7) | >0.99b |
Requiring ICU admission, n (%) | 4 (67) | 47 (47) | 0.43b |
With intubation | 3 (50) | 42 (42) | >0.99b |
Discharged, n (%) | 2 (33) | 46 (46) | 0.69b |
Deceased, n (%) | 2 (33) | 11 (11) | 0.16 |